Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Efficacy, Safety and Tolerability of a Single and a Repeated Dose of Oral BCT197 in Patients With an Acute COPD Exacerbation

NCT01332097 is registered in ClinicalTrials.gov with Mereo BioPharma as lead sponsor.

NCT NCT01332097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01332097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Efficacy, Safety and Tolerability of a Single and a Repeated Dose of Oral BCT197 in Patients With an Acute COPD Exacerbation
Lead sponsor
Mereo BioPharma
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
May 31, 2013
Enrollment
183 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease